Literature DB >> 9169588

Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

M L Billingsley1, R L Kincaid.   

Abstract

This review attempts to summarize what is known about tau phosphorylation in the context of both normal cellular function and dysfunction. However, conceptions of tau function continue to evolve, and it is likely that the regulation of tau distribution and metabolism is complex. The roles of microtubule-associated kinases and phosphatases have yet to be fully described, but may afford insight into how tau phosphorylation at the distal end of the axon regulates cytoskeletal-membrane interactions. Finally, lipid and glycosaminoglycan modification of tau structure affords yet more complexity for regulation and aggregation. Continued work will help to determine what is causal and what is coincidental in Alzheimer's disease, and may lead to identification of therapeutic targets for halting the progression of paired helical filament formation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169588      PMCID: PMC1218358          DOI: 10.1042/bj3230577

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  207 in total

1.  Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; non-phosphorylated epitopes precede phosphorylation.

Authors:  J Savory; Y Huang; M M Herman; M R Wills
Journal:  Brain Res       Date:  1996-01-29       Impact factor: 3.252

2.  Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L.

Authors:  E Bednarski; G Lynch
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

Review 3.  Cyclins and cyclin-dependent kinases: a biochemical view.

Authors:  J Pines
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

Review 4.  Serine/threonine protein phosphatases.

Authors:  S Wera; B A Hemmings
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

5.  Okadaic acid induces hyperphosphorylation of tau independently of mitogen-activated protein kinase activation.

Authors:  D T Ho; H Shayan; T H Murphy
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

6.  Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.

Authors:  T Arendt; M Holzer; A Grossmann; D Zedlick; M K Brückner
Journal:  Neuroscience       Date:  1995-09       Impact factor: 3.590

7.  Calpain-induced proteolysis of normal human tau and tau associated with paired helical filaments.

Authors:  L S Yang; H Ksiezak-Reding
Journal:  Eur J Biochem       Date:  1995-10-01

8.  Quantitative analysis of tau protein in paired helical filament preparations: implications for the role of tau protein phosphorylation in PHF assembly in Alzheimer's disease.

Authors:  C M Wischik; P C Edwards; R Y Lai; H N Gertz; J H Xuereb; E S Paykel; C Brayne; F A Huppert; E B Mukaetova-Ladinska; R Mena
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

9.  Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain.

Authors:  R Brandt; J Léger; G Lee
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

10.  Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.

Authors:  S Miyamoto; H Teramoto; O A Coso; J S Gutkind; P D Burbelo; S K Akiyama; K M Yamada
Journal:  J Cell Biol       Date:  1995-11       Impact factor: 10.539

View more
  105 in total

1.  Glycogen Synthase Kinase 3β-mediated Phosphorylation in the Most C-terminal Region of Protein Interacting with C Kinase 1 (PICK1) Regulates the Binding of PICK1 to Glutamate Receptor Subunit GluA2.

Authors:  Sosuke Yagishita; Miyuki Murayama; Tomoe Ebihara; Kei Maruyama; Akihiko Takashima
Journal:  J Biol Chem       Date:  2015-10-15       Impact factor: 5.157

2.  Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Authors:  K Spittaels; C Van den Haute; J Van Dorpe; K Bruynseels; K Vandezande; I Laenen; H Geerts; M Mercken; R Sciot; A Van Lommel; R Loos; F Van Leuven
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer's disease.

Authors:  Narendran Annadurai; Khushboo Agrawal; Petr Džubák; Marián Hajdúch; Viswanath Das
Journal:  Cell Mol Life Sci       Date:  2017-06-20       Impact factor: 9.261

4.  Phosphorylation-Mediated Clearance of Amyloid-like Assemblies in Meiosis.

Authors:  Kayla Carpenter; Rachel Brietta Bell; Julius Yunus; Angelika Amon; Luke Edwin Berchowitz
Journal:  Dev Cell       Date:  2018-05-07       Impact factor: 12.270

5.  Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.

Authors:  Manel G Medina; Maria Dolores Ledesma; Jorge E Domínguez; Miguel Medina; Delia Zafra; Francesc Alameda; Carlos G Dotti; Pilar Navarro
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

Review 6.  Amyloidogenesis of natively unfolded proteins.

Authors:  Vladimir N Uversky
Journal:  Curr Alzheimer Res       Date:  2008-06       Impact factor: 3.498

Review 7.  Biomarker modelling of early molecular changes in Alzheimer's disease.

Authors:  Ross W Paterson; Jamie Toombs; Catherine F Slattery; Jonathan M Schott; Henrik Zetterberg
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 8.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 9.  Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer's disease.

Authors:  Jangampalli Adi Pradeepkiran; Arubala P Reddy; P Hemachandra Reddy
Journal:  Drug Discov Today       Date:  2018-11-16       Impact factor: 7.851

Review 10.  A common biological mechanism in cancer and Alzheimer's disease?

Authors:  M I Behrens; C Lendon; C M Roe
Journal:  Curr Alzheimer Res       Date:  2009-06       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.